Canada markets open in 6 hours 3 minutes

Vaxil Bio Ltd. (VXL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.02000.0000 (0.00%)
At close: 12:13PM EST
Full screen
Previous Close0.0200
Open0.0200
Bid0.0200 x 0
Ask0.0250 x 0
Day's Range0.0200 - 0.0200
52 Week Range0.0100 - 0.0650
Volume116,500
Avg. Volume114,547
Market Cap2.74M
Beta (5Y Monthly)-3.43
PE Ratio (TTM)N/A
EPS (TTM)-0.0060
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Vaxil Provides Update on Research Activities

    Not for distribution by US newswire or in United States NESS-ZIONA, Israel, March 07, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company is pleased to provide an update on its research activities. Vaxil previously reported therapeutic success of P-Esbp-DOX, a novel anti-cancer drug, when tested in vivo in a mouse model of aggressive liver metastasis of colorectal cancer (CRC). P-Esbp-DOX was developed by Prof. Ayelet

  • GlobeNewswire

    Vaxil’s Annual and Special Shareholders Meeting

    Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Feb. 08, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases, announces that at the Company's Annual and Special General Meeting, held virtually, on February 7, 2022, all resolutions were duly passed by shareholders. ABOUT VAXIL Vaxil is an Israeli immunotherapy biotech company focused on its nove